Hims: An oral-kit path or an injectable GLP-1 path
Semaglutide is the most widely prescribed GLP-1 agonist, with an extensive evidence base spanning diabetes, obesity, and cardiovascular outcomes
Cohen's newer venture, the precision-medicine biotech MENTSH Therapeutics, carries the work forward, and in April 2025 he joined the scientific advisory board of Niagen Bioscience (the NAD+ company formerly known as ChromaDex), whose CEO Rob Fried described the appointment as a chance to "learn from one of the great minds in mitochondrial and longevity research."14 The lesson for buyers: promising biology and a durable product are different things, and the gap between them is where a lot of money and hope get lost
Sweeteners also function as excipients in various pharmaceuticals (Rowe et al, 2009), such as antihypertensives, and are co-ingested with long-term medications like antidepressants that are consumed by millions of people daily (World Population Review, 2022)
A supplement especially during a diet can thus help achieve goals during diet and weight control
